Phoenix Biotech Acquisition Statistics Share Statistics Phoenix Biotech Acquisition has n/a
shares outstanding. The number of shares has increased by 193.14%
in one year.
Shares Outstanding n/a Shares Change (YoY) 193.14% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 3.35M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 86, so 0% of the outstanding
shares have been sold short.
Short Interest 86 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.65
Valuation Ratios The PE ratio is -26.21 and the forward
PE ratio is null.
Phoenix Biotech Acquisition's PEG ratio is
0.
PE Ratio -26.21 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -153.39 P/FCF Ratio -50.19 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Phoenix Biotech Acquisition.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.5,
with a Debt / Equity ratio of -0.83.
Current Ratio 0.5 Quick Ratio 0.5 Debt / Equity -0.83 Debt / EBITDA -0.1 Debt / FCF -0.27 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.04, so Phoenix Biotech Acquisition's
price volatility has been higher than the market average.
Beta 0.04 52-Week Price Change n/a 50-Day Moving Average 10.69 200-Day Moving Average 10.76 Relative Strength Index (RSI) 41.92 Average Volume (20 Days) 97
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.2M Net Income -11.09M EBITDA -16.2M EBIT n/a Earnings Per Share (EPS) -0.22
Full Income Statement Balance Sheet The company has 3.33M in cash and 1.58M in
debt, giving a net cash position of 1.75M.
Cash & Cash Equivalents 3.33M Total Debt 1.58M Net Cash 1.75M Retained Earnings -70.92M Total Assets 7.99M Working Capital -2.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.79M
and capital expenditures 0, giving a free cash flow of -5.79M.
Operating Cash Flow -5.79M Capital Expenditures n/a Free Cash Flow -5.79M FCF Per Share -0.12
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
